Summit Therapeutics (NASDAQ:SMMT) said it has received and accepted an unsolicited offer from an institutional investor to purchase 22.22M shares at $9 apiece. Shares in the company were up 13.4% in ...
Source LinkSummit Therapeutics (NASDAQ:SMMT) said it has received and accepted an unsolicited offer from an institutional investor to purchase 22.22M shares at $9 apiece. Shares in the company were up 13.4% in ...
Source Link
Comments